Low-Dose Nutrient Mix Shows Promise in Easing Autism Symptoms in Mice

A new study has found that a low-dose nutrient mixture can ease behavioural symptoms in mice with autism spectrum disorder (ASD). The cocktail, containing zinc, serine, and branch-chain amino acids (BCAAs), improved social interactions and brain function in three different mouse models. Researchers suggest this approach could offer a safer, broader treatment option for ASD.

ASD is marked by difficulties in social behaviour, communication, and repetitive actions. It stems from abnormal neural development, affecting how brain cells connect and interact. With hundreds of genes linked to the condition, a single-gene therapy seems unlikely.

The study tested a low-dose blend of zinc, serine, and BCAAs on mice with ASD-like traits. The mixture reduced abnormal neuron activity in the amygdala, a brain region tied to emotional processing. After treatment, the animals' brain protein levels resembled those of healthy mice.

Social behaviours also improved in three ASD mouse models: Shank2 mice, Nf1 mice, and Cttnbp2 mice. The nutrients worked together, enhancing neuron communication and reducing hyperactivity. Researchers noted that the low dosage made the treatment safer for potential long-term use.

While past studies on diets like the gluten-free, casein-free (GFCF) approach have shown mixed results in humans, no current clinical trials are testing this specific nutrient cocktail. Earlier research lacked clear details on dosage, safety, and long-term effects in people with ASD.

The findings suggest that a simple nutrient mix could help address behavioural and brain function issues in ASD. Unlike gene-specific therapies, this approach may work across different genetic causes of the disorder. Further research is needed to determine its safety and effectiveness in humans.